Company Performance: Periphas Bio's financial health, revenue growth, profitability, and success in clinical trials strongly influence investor confidence.

Pharmaceutical Industry Trends: Overall industry growth, regulatory changes, and competitor activities in the drug development space impact investor sentiment.

Clinical Trial Results: Positive data from clinical trials for Periphas Bio's drug candidates drive the stock price up, while negative results can cause it to fall.

Regulatory Approvals: FDA or other regulatory agency approvals for Periphas Bio's drugs are major catalysts for stock appreciation.

Market Sentiment: General investor mood, economic conditions, and risk appetite influence stock prices, impacting PRPH even without company-specific news.

News and Events: Announcements about partnerships, acquisitions, or presentations at scientific conferences can affect PRPH's stock price.

Competition: The presence of competing drugs or therapies from other pharmaceutical companies can create downward pressure on PRPH's stock price.

Intellectual Property: The strength and duration of Periphas Bio's patents for its drug candidates impact its competitive advantage and stock value.

Financial News: Financial reports by Periphas Bio and commentary about the stock can influence the price.

Economic factors: Macroeconomics factors such as inflation and interest rates can play a role in pricing.